| SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of … XX Wang, J Levi, Y Luo, K Myakala, M Herman-Edelstein, L Qiu, D Wang, ... Journal of Biological Chemistry 292 (13), 5335-5348, 2017 | 290 | 2017 |
| FXR/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity XX Wang, D Wang, Y Luo, K Myakala, E Dobrinskikh, AZ Rosenberg, ... Journal of the American Society of Nephrology 29 (1), 118-137, 2018 | 157 | 2018 |
| The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents renal and liver disease in western diet induced obesity mice D Wang, Y Luo, X Wang, DJ Orlicky, K Myakala, P Yang, M Levi International journal of molecular sciences 19 (1), 137, 2018 | 90 | 2018 |
| Intestinal Depletion of NaPi‐IIb/Slc34a2 in Mice: Renal and Hormonal Adaptation N Hernando, K Myakala, F Simona, T Knöpfel, L Thomas, H Murer, ... Journal of Bone and Mineral Research 30 (10), 1925-1937, 2015 | 63 | 2015 |
| Renal-specific and inducible depletion of NaPi-IIc/Slc34a3, the cotransporter mutated in HHRH, does not affect phosphate or calcium homeostasis in mice K Myakala, S Motta, H Murer, CA Wagner, R Koesters, J Biber, ... American Journal of Physiology-Renal Physiology 306 (8), F833-F843, 2014 | 55 | 2014 |
| Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet–fed mice S Takahashi, Y Luo, S Ranjit, C Xie, AE Libby, DJ Orlicky, A Dvornikov, ... Journal of Biological Chemistry 295 (14), 4733-4747, 2020 | 45 | 2020 |
| Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats D Wang, Y Luo, K Myakala, DJ Orlicky, E Dobrinskikh, X Wang, M Levi Scientific reports 7 (1), 9793, 2017 | 42 | 2017 |
| A user-friendly tool for cloud-based whole slide image segmentation with examples from renal histopathology B Lutnick, D Manthey, JU Becker, B Ginley, K Moos, JE Zuckerman, ... Communications medicine 2 (1), 105, 2022 | 22 | 2022 |
| Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment K Myakala, BA Jones, XX Wang, M Levi American Journal of Physiology-Renal Physiology 320 (6), F1133-F1151, 2021 | 22 | 2021 |
| The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice XX Wang, C Xie, AE Libby, S Ranjit, J Levi, K Myakala, K Bhasin, ... Journal of Biological Chemistry 298 (11), 2022 | 17 | 2022 |
| PodoCount: a robust, fully automated, whole-slide podocyte quantification tool BA Santo, D Govind, P Daneshpajouhnejad, X Yang, XX Wang, ... Kidney International Reports 7 (6), 1377-1392, 2022 | 13 | 2022 |
| ERR agonism reverses mitochondrial dysfunction and inflammation in aging XX Wang, K Myakala, AE Libby, J Panov, S Ranjit, ST Jones, B A, ... The American Journal of Pathology, 2023, 755801, 2023 | 11* | 2023 |
| Empagliflozin treatment attenuates hepatic steatosis by promoting white adipose expansion in obese TallyHo mice R Kurtz, A Libby, BA Jones, K Myakala, X Wang, Y Lee, G Knoer, ... International journal of molecular sciences 23 (10), 5675, 2022 | 11 | 2022 |
| NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease K Myakala, XX Wang, NV Shults, E Krawczyk, BA Jones, X Yang, ... Journal of Biological Chemistry 299 (8), 2023 | 8 | 2023 |
| SRGAP2a: a new player that modulates podocyte cytoskeleton and injury in diabetes M Levi, K Myakala, X Wang Diabetes 67 (4), 550, 2018 | 6 | 2018 |
| Endothelial cell-specific molecule-1 inhibits albuminuria in diabetic mice X Zheng, L Higdon, A Gaudet, M Shah, A Balistieri, C Li, P Nadai, ... Kidney360 3 (12), 2059-2076, 2022 | 4 | 2022 |
| Nuclear receptors and transcription factors in obesity-related kidney disease BA Jones, XX Wang, K Myakala, M Levi Seminars in nephrology 41 (4), 318-330, 2021 | 4 | 2021 |
| Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease BA Jones, K Myakala, M Guha, S Davidson, S Adapa, I Lopez Santiago, ... American Journal of Physiology-Renal Physiology 325 (6), F792-F810, 2023 | 1 | 2023 |
| PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy T Yoshida, KZ Latt, AZ Rosenberg, BA Santo, K Myakala, Y Ishimoto, ... bioRxiv, 2022.10. 03.510678, 2022 | 1 | 2022 |
| Phosphate homeostasis: role of renal and intestinal transporters N Hernando, J Ruminska, K Myakala, T Knoepfel, J Biber, H Murer, ... Acta Physiologica 219, 9-9, 2017 | 1 | 2017 |
